Colloid solution for preparing suspension having both fluidity and
suspensibility
    6.
    发明授权
    Colloid solution for preparing suspension having both fluidity and suspensibility 失效
    用于制备具有流动性和悬浮性的悬浮液的胶体溶液

    公开(公告)号:US5180522A

    公开(公告)日:1993-01-19

    申请号:US165013

    申请日:1988-03-04

    CPC分类号: A61K9/0095 A61K9/10

    摘要: A colloid solution for preparing a suspension, containing one or more components selected from Group A and one or more components selected from Group B as dispersoids, and water as a dispersant medium, the colloid solution being at a pH such that suspensoid particles added thereto are positively charged; wherein Group A consists of xylitol, D-sorbitol, D-mannitol, lactose, saccharose, cyclodextrin, maltose, D-fructose, D-glucose and galactose; and Group B consists of sodium carboxymethylcellulose, sodium alginate, sodium polyacrylate and gum arabic.

    摘要翻译: 一种用于制备悬浮液的胶体溶液,其含有选自A组的一种或多种组分和选自B组分为分散体的一种或多种组分,以及作为分散剂介质的水,所述胶体溶液的pH值使得添加悬浮颗粒的是 正电荷 其中A组由木糖醇,D-山梨糖醇,D-甘露糖醇,乳糖,蔗糖,环糊精,麦芽糖,D-果糖,D-葡萄糖和半乳糖组成; B组由羧甲基纤维素钠,藻酸钠,聚丙烯酸钠和阿拉伯树胶组成。

    Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders
    9.
    发明授权
    Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders 有权
    卡波他汀衍生物和5-羟色胺再摄取抑制剂治疗情绪障碍

    公开(公告)号:US08759350B2

    公开(公告)日:2014-06-24

    申请号:US10540577

    申请日:2003-12-25

    摘要: The pharmaceutical composition of the present invention comprises (1) a carbostyril derivative and (2) a serotonin reuptake inhibitor in a pharmaceutically acceptable carrier. The carbostyril derivative may be aripiprazole or a metabolite thereof, which is a dopamine-serotonin system stabilizer. The serotonin reuptake inhibitor may be fluoxetine, duloxetine, venlafaxine, milnacipran, citalopram, fluvoxamine, paroxetine, sertraline or escitalopram. The pharmaceutical composition of the present invention is useful for treating patients with mood disorders, particularly depression or major depressive disorder.

    摘要翻译: 本发明的药物组合物包含(1)喹诺酮衍生物和(2)可药用载体中的5-羟色胺再摄取抑制剂。 喹诺酮类衍生物可以是阿立哌唑或其代谢物,其是多巴胺5-羟色胺系统稳定剂。 5-羟色胺再摄取抑制剂可以是氟西汀,度洛西汀,文拉法辛,米那普仑,西酞普兰,氟伏沙明,帕罗西汀,舍曲林或依他普仑。 本发明的药物组合物可用于治疗情绪障碍,特别是抑郁症或重度抑郁症的患者。

    Driving assist device for vehicle
    10.
    发明授权
    Driving assist device for vehicle 有权
    车辆驾驶辅助装置

    公开(公告)号:US08212659B2

    公开(公告)日:2012-07-03

    申请号:US12489054

    申请日:2009-06-22

    申请人: Taro Iwamoto

    发明人: Taro Iwamoto

    IPC分类号: B60Q1/00 G08G1/16 B60T7/16

    CPC分类号: B60W50/14 B60W30/08

    摘要: An alarm sound according to the distance of a dangerous object exiting around a vehicle is created. A reference sound which enables a driver to recognize the distance of the dangerous object when the driver hears the alarm sound, comparing with the reference sound, is created. The alarm sound and the reference sound are generated at the same time or a different timing. It is preferable that the sound volume of the alarm sound be greater than that of the reference sound. Accordingly, the driver can be warned precisely of the distance of the dangerous object from the vehicle with the sound.

    摘要翻译: 产生根据车辆周围出现危险物体的距离的报警声。 创建与参考声音相比,当驾驶员听到警报声音时,能够使驾驶员识别危险物体的距离的参考声音。 报警声和参考声音同时或不同的时间产生。 优选地,警报声音的音量大于参考声音的音量。 因此,驾驶员可以精确地警告危险物体与车辆的距离与声音。